- Home
- GLNG vs INAB Comparison
GLNG vs INAB Comparison
Compare GLNG & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLNG
- INAB
- Stock Information
- Founded
- GLNG 1946
- INAB 2016
- Country
- GLNG Bermuda
- INAB United States
- Employees
- GLNG N/A
- INAB N/A
- Industry
- GLNG Marine Transportation
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- GLNG Consumer Discretionary
- INAB Health Care
- Exchange
- GLNG Nasdaq
- INAB Nasdaq
- Market Cap
- GLNG N/A
- INAB 24.0M
- IPO Year
- GLNG N/A
- INAB 2021
- Fundamental
- Price
- GLNG $42.06
- INAB $0.25
- Analyst Decision
- GLNG Strong Buy
- INAB Strong Buy
- Analyst Count
- GLNG 5
- INAB 3
- Target Price
- GLNG $48.70
- INAB $7.75
- AVG Volume (30 Days)
- GLNG 1.4M
- INAB 841.3K
- Earning Date
- GLNG 01-07-2025
- INAB 11-12-2024
- Dividend Yield
- GLNG 2.39%
- INAB N/A
- EPS Growth
- GLNG N/A
- INAB N/A
- EPS
- GLNG 0.13
- INAB N/A
- Revenue
- GLNG $274,134,000.00
- INAB N/A
- Revenue This Year
- GLNG N/A
- INAB N/A
- Revenue Next Year
- GLNG $59.56
- INAB N/A
- P/E Ratio
- GLNG $323.90
- INAB N/A
- Revenue Growth
- GLNG N/A
- INAB N/A
- 52 Week Low
- GLNG $19.94
- INAB $0.22
- 52 Week High
- GLNG $44.08
- INAB $1.93
- Technical
- Relative Strength Index (RSI)
- GLNG 54.96
- INAB 46.54
- Support Level
- GLNG $40.40
- INAB $0.28
- Resistance Level
- GLNG $42.99
- INAB $0.26
- Average True Range (ATR)
- GLNG 1.30
- INAB 0.03
- MACD
- GLNG -0.22
- INAB -0.00
- Stochastic Oscillator
- GLNG 36.95
- INAB 31.54
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.